| View |
|
DR-XY37836
|
Glimepiride
|
Diameride
|
1mg
|
Tablet
|
-
|
Intas Pharmaceuticals Limited
|
India
|
-
|
17 January 2020
|
26 April 2025
|
| View |
|
DR-XY37838
|
Alendronic Acid (as Alendronate Sodium)
|
Osteomax
|
70 mg
|
Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
12 October 2020
|
28 April 2025
|
| View |
|
DR-XY3784
|
Kedar
|
Homatropine Methylbromide
|
5 mg/5 mL
|
Syrup
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
20 May 2021
|
31 May 2026
|
| View |
|
DR-XY37843
|
Ceratim
|
Cefotiam (As Hydrochloride)
|
1 g
|
Powder For Injection (IM/IV)
|
-
|
Singapore Pharmawealth Lifesciences, Inc.
|
Philippines
|
-
|
07 May 2021
|
27 April 2025
|
| View |
|
DR-XY37849
|
Amlodipine (As Besilate)
|
Ambloc
|
5 mg
|
Tablet
|
-
|
Unison Laboratories Co., Ltd.
|
Thailand
|
-
|
20 May 2021
|
17 March 2026
|
| View |
|
DR-XY3785
|
Homatropine Methylbromide
|
Kedar
|
5 mg
|
Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
18 June 2020
|
30 September 2025
|
| View |
|
DR-XY37854
|
Fungystine
|
Nystatin
|
100,000 Units
|
Vaginal Insert
|
-
|
Swiss Pharma Research Laboratories, Inc.
|
Philippines
|
-
|
20 May 2021
|
27 April 2025
|
| View |
|
DR-XY37855
|
Nystatin
|
Fungystine
|
100,000 units/mL
|
Suspension
|
-
|
Swisspharma Research Laboratories, Inc.
|
Philippines
|
-
|
17 November 2021
|
27 April 2025
|
| View |
|
DR-XY37857
|
Ambroxol (As Hydrochloride)
|
Ambroflam
|
30 mg
|
Tablet
|
-
|
Flamingo Pharmaceuticals Co. Ltd.,
|
India
|
-
|
20 November 2020
|
28 April 2025
|
| View |
|
DR-XY37859
|
Metformin Hydrochloride
|
Dimet-500
|
500mg
|
Film-Coated Tablet
|
-
|
Oman Pharmaceutical Products Co. L.L.C.
|
Oman
|
-
|
08 April 2020
|
28 April 2025
|
| View |
|
DR-XY37865
|
Levocetirizine Dihydrochloride
|
Allerzet
|
2.5 mg/5 mL
|
Syrup
|
Antihistamine (Piperazine Derivative)
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
15 September 2022
|
03 October 2027
|
| View |
|
DR-XY37880
|
Allopurinol
|
Urisol
|
100 mg
|
Tablet
|
-
|
Centurion Laboratories (Division of Centurion Remedies Pvt. Ltd.)
|
India
|
-
|
18 June 2020
|
04 May 2025
|
| View |
DR-XY37883_PI_01.pdf
|
DR-XY37883
|
Amlodipine (As Besilate) + Olmesartan Medoxomil
|
Normetec
|
10 mg/40 mg
|
Film-Coated Tablet
|
Angiotensin II receptor blockers (ARBs) and Calcium Channel Blocker
|
Daiichi Sankyo Europe GmbH
|
Germany
|
Initial (from Monitored release)
|
22 April 2022
|
29 April 2025
|
| View |
DR-XY37884_PI_01.pdf
|
DR-XY37884
|
Amlodipine (As Besilate) + Olmesartan Medoxomil
|
Normetec
|
5 mg/40 mg
|
Film-Coated Tablet
|
Angiotensin II receptor blockers (ARBs) and Calcium Channel Blocker
|
Daiichi Sankyo Europe GmbH
|
Germany
|
Initial (from Monitored release)
|
22 April 2022
|
29 April 2025
|
| View |
DR-XY37885_PI_01.pdf
|
DR-XY37885
|
Amlodipine (As Besilate) + Olmesartan Medoxomil
|
Normetec
|
5 mg/20 mg
|
Film-Coated Tablet
|
Angiotensin II receptor blockers (ARBs) and Calcium Channel Blocker
|
Daiichi Sankyo Europe GmbH
|
Germany
|
Initial (from Monitored release)
|
22 April 2022
|
29 April 2025
|
| View |
|
DR-XY37891
|
Enalapril Maleate +Hydrochlorothiazide
|
Co-Hypace
|
20 mg/12.5 mg
|
tablet
|
-
|
Pascual Laboratories, Inc.
|
Philippines
|
-
|
08 November 2021
|
04 May 2025
|
| View |
|
DR-XY37905
|
LATANOPROST
|
IOPROST
|
50mcg/ mL (0.005%)
|
Ophthalmic Solution
|
Medicines for Glaucoma (Prostaglandin analogues)
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
13 April 2023
|
16 July 2028
|
| View |
|
DR-XY37906
|
Dapoxetine (as hydrochloride)
|
Priligy
|
30mg
|
Film-Coated Tablet
|
-
|
Menarini -Von Heyden GmbH
|
Germany
|
Initial
|
10 August 2022
|
01 April 2026
|
| View |
|
DR-XY37907
|
Dapoxetine (as hydrochloride)
|
Priligy
|
60 mg
|
Film-Coated Tablet
|
-
|
Menarini -Von Heyden GmbH
|
Germany
|
Initial
|
10 August 2022
|
01 April 2026
|
| View |
|
DR-XY37916
|
Zaran
|
Losartan Potassium
|
50 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
17 May 2021
|
11 May 2025
|